← Back to headlines
Novo Nordisk Seeks Injunction Against Eli Lilly Weight-Loss Drug Ads
Novo Nordisk has filed for a preliminary injunction to block Eli Lilly's advertisements for its weight-loss drug. Novo Nordisk is pursuing legal action to prevent the competitor's marketing campaign.
24 Jul, 10:16 — 24 Jul, 12:03
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (47/100)4 sources30/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left2
Left (2)
politikencnbc
Center
Right2
Right (2)
seeking-alphaberlingske
Far R
Geographic diversity— 2 regions9/34
US2Denmark2
Sources
Showing 2 of 4 sources
cnbcMostly Factual1d ago
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads
Denmark's Novo Nordisk said on Tuesday that it had sued Lilly, arguing consumers were being misled about how the companies' products compare.
Read full article →seeking-alphaMixed1d ago
Novo files injunction to block Lilly’s weight-loss drug ads (update)
Read full article →Coverage Timeline
First report: berlingske · 24 Jul, 10:09|Full coverage: 4 · 2h|Window: 2h
Left-leaningCenterRight-leaning
Related Stories
African Nations Adopt Plan for Cheaper Internet and Smartphones
just now
Europe Embraces Third Wave of Digital Identity, Moving Beyond Passwords
11m ago
Consumer Expectations Drive Digitalization, Says Tech Expert
19m ago
Hungary's First Robotic Arrhythmia Treatment System Begins Operation in Szeged
23m ago